about
gamma-aminobutyric acid type B receptors are expressed and functional in mammalian cardiomyocytesGamma-hydroxybutyric acid: an emerging recreational drug.Physostigmine as a treatment for gamma-hydroxybutyrate toxicity: a review.Behavioral effects of gamma-hydroxybutyrate in humansA comprehensive review of MDMA and GHB: two common club drugs.Gamma hydroxybutyric acid (GHB) intoxication.Different actions of gamma-hydroxybutyrate: a critical outlook.A single acute pharmacological dose of γ-hydroxybutyrate modifies multiple gene expression patterns in rat hippocampus and frontal cortex.ConceptMetab: exploring relationships among metabolite sets to identify links among biomedical concepts.Mechanisms for the Specific Properties of γ-Hydroxybutyrate in Brain.In vitro modulation of hippocampal pyramidal cell response by quinolones: effects of HA 966 and gamma-hydroxybutyric acid.Does gamma-hydroxybutyrate inhibit or stimulate central DA release?GHB-induced delirium: a case report and review of the literature of gamma hydroxybutyric acid.Pharmacokinetics of gamma-hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses.gamma-Hydroxybutyrate modulation of glutamate levels in the hippocampus: an in vivo and in vitro study.Gamma-hydroxybutyrate stimulation of the formation of cyclic GMP and inositol phosphates in rat hippocampal slices.Use of GHB compounds among college students.Analysis of γ-hydroxy butyrate by combining capillary electrophoresis-indirect detection and wall dynamic coating: application to dried matrices.Neuronal oscillations and synchronicity associated with gamma-hydroxybutyrate during resting-state in healthy male volunteers.A sudden awakening from a near coma after combined intake of gamma-hydroxybutyric acid (GHB) and ethanol.Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine.gamma-Hydroxybutyric acid in the treatment of alcohol dependence: a double-blind study.β-Carbolines in alcohol-dependent intensive care patients during prophylactics and therapy of alcohol withdrawal syndrome.
P2860
Q30886242-51E71381-9CB4-4CEB-B872-58EEC7BC1EDFQ33588063-C9CC0258-5192-4527-B6A5-0896CFEDA567Q33963037-26B9F169-A890-4FD4-A7FD-B4FA206735E1Q34026042-B2F58B2E-1953-4090-8AAF-C83157BDE91DQ34476901-03413A4F-B3BC-45D6-90FD-5530CDD15FE5Q34717709-38FDC598-AA41-4FD7-9ED8-306A0AED7542Q35568436-61FD292E-BB6F-4A8D-BB1D-591F7F633F65Q38346952-F5E2086A-7929-4E68-9528-521739E10FF2Q38396930-BD7722EF-B6FF-40D0-9BCE-ABF584F2B6CDQ38688873-BD596FD8-5E8F-4DAD-97DE-3D148D45A941Q39783134-5F0ACA57-0DF0-48EB-8010-3A0CB28E478FQ41325297-58E56FB3-396E-429C-B3EA-4527109C5E1FQ41726055-0611D82E-3944-4402-A5AE-69B59AB5A9DFQ41841648-4C2F7617-BFBA-4647-8FDB-DE5129A90C0FQ43735178-41DF382C-0386-4EA8-A720-0CEE46949A03Q45906182-FEE988C2-0686-44AD-A4B1-BF64FD7970DBQ46352597-580F64A3-3C51-4FB5-9588-183C5AC03E01Q47645271-560B4AF5-E0E2-47C3-8E08-003A251B39ABQ47739628-D259C644-6E13-48C0-A052-B7865CD31FBAQ49096535-68E1E7CB-0ACD-4818-BC82-F482FC5E835EQ51084803-BDFDAAC3-507A-454E-A81E-19CD5CB95829Q51686803-8A11BCC2-A61A-4881-AF55-119968C42CE9Q52994373-15889361-7013-4C85-A268-4720BC241C39
P2860
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Gamma-hydroxybutyrate, a possible neurotransmitter.
@en
Gamma-hydroxybutyrate, a possible neurotransmitter.
@nl
type
label
Gamma-hydroxybutyrate, a possible neurotransmitter.
@en
Gamma-hydroxybutyrate, a possible neurotransmitter.
@nl
prefLabel
Gamma-hydroxybutyrate, a possible neurotransmitter.
@en
Gamma-hydroxybutyrate, a possible neurotransmitter.
@nl
P1433
P1476
Gamma-hydroxybutyrate, a possible neurotransmitter
@en
P2093
P304
P356
10.1016/0024-3205(87)90721-1
P407
P577
1987-09-01T00:00:00Z